Gene Delivery Systems
暂无分享,去创建一个
[1] N. Brunetti‐Pierri. Helper-dependent adenoviral vectors for gene therapy , 2014 .
[2] I. Alferiev,et al. Adenoviral vector tethering to metal surfaces via hydrolyzable cross-linkers for the modulation of vector release and transduction. , 2013, Biomaterials.
[3] Jun Chang,et al. Viral vectors for vaccine applications , 2013, Clinical and experimental vaccine research.
[4] Pavel Zrazhevskiy,et al. Quantum dots as a platform for nanoparticle drug delivery vehicle design. , 2013, Advanced drug delivery reviews.
[5] D. Agrawal,et al. Clinical and Translational Challenges in Gene Therapy of Cardiovascular Diseases , 2013 .
[6] M. Nakanishi,et al. Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine , 2012, Current gene therapy.
[7] U. Krishnan,et al. Translational siRNA therapeutics using liposomal carriers: prospects & challenges. , 2012, Current gene therapy.
[8] O. Tolmachov. Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: a new concept for improvement of non-viral therapeutic gene delivery. , 2012, Medical hypotheses.
[9] Y. Meir,et al. Transposon-based vector systems for gene therapy clinical trials: challenges and considerations. , 2011, Chang Gung medical journal.
[10] Rinti Banerjee,et al. Nanostructured self assembled lipid materials for drug delivery and tissue engineering. , 2011, Therapeutic delivery.
[11] Christian Plank,et al. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection—Progress and prospects , 2011, Advanced Drug Delivery Reviews.
[12] O. Mykhaylyk,et al. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. , 2011, Blood.
[13] R. Compans,et al. Induction of Influenza-Specific Mucosal Immunity by an Attenuated Recombinant Sendai Virus , 2011, PloS one.
[14] H. Nakauchi,et al. Development of Defective and Persistent Sendai Virus Vector , 2010, The Journal of Biological Chemistry.
[15] Murali M. Yallapu,et al. PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging Applications , 2010, Pharmaceutical Research.
[16] Stefan Thalhammer,et al. Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. , 2010, Molecular pharmaceutics.
[17] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[18] T. Daniels,et al. A versatile targeting system with lentiviral vectors bearing the biotin‐adaptor peptide , 2009, The journal of gene medicine.
[19] Robert J Levy,et al. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. , 2009, Molecular pharmaceutics.
[20] Peter Wipf,et al. Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.
[21] Ning Wang,et al. Mechanochemical delivery and dynamic tracking of fluorescent quantum dots in the cytoplasm and nucleus of living cells. , 2009, Nano letters.
[22] Sangjin Park,et al. Carbon nanosyringe array as a platform for intracellular delivery. , 2009, Nano letters.
[23] J. Glorioso,et al. Therapeutic Gene Transfer with Replication-Defective Herpes Simplex Viral Vectors , 2008 .
[24] A. Schambach,et al. Retroviral Vectors for Cell and Gene Therapy , 2008 .
[25] K. Airenne,et al. Targeting and purification of metabolically biotinylated baculovirus. , 2008, Human gene therapy.
[26] Paul H Lerou,et al. Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.
[27] M. Barry,et al. Current advances and future challenges in Adenoviral vector biology and targeting. , 2007, Current gene therapy.
[28] K. Longmuir,et al. Effective Targeting of Liposomes to Liver and Hepatocytes In Vivo by Incorporation of a Plasmodium Amino Acid Sequence , 2006, Pharmaceutical Research.
[29] G. Mufti,et al. Conjugation of Lentivirus to Paramagnetic Particles via Nonviral Proteins Allows Efficient Concentration and Infection of Primary Acute Myeloid Leukemia Cells , 2005, Journal of Virology.
[30] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[31] T. Brill,et al. Advances in magnetofection—magnetically guided nucleic acid delivery , 2005 .
[32] A. Panet,et al. Synchronized Infection of Cell Cultures by Magnetically Controlled Virus , 2005, Journal of Virology.
[33] M. Imperiale,et al. Biology of adenovirus and its use as a vector for gene therapy. , 2004, Human gene therapy.
[34] Varpu Marjomäki,et al. Enhanced gene delivery by avidin-displaying baculovirus. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[35] S. Kochanek,et al. Adenoviral vectors for gene transfer and therapy , 2004, The journal of gene medicine.
[36] B. Carter,et al. Adeno-associated Virus and AAV Vectors for Gene Delivery , 2003 .
[37] R. Crystal,et al. Adenovirus Vectors for Gene Therapy , 2003 .
[38] U. Greber,et al. Adenovirus endocytosis , 2003, The journal of gene medicine.
[39] M. Sandri,et al. Electrotransfer in differentiated myotubes: a novel, efficient procedure for functional gene transfer. , 2003, Experimental cell research.
[40] Wei‐Yin Sun,et al. Electrochemically driven clathration/declathration of ferrocene and its derivatives by a nanometer-sized coordination cage. , 2002, Journal of the American Chemical Society.
[41] Jon Dobson,et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] P. Quax,et al. Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease , 2002, Journal of Virology.
[43] J. Roy-Chowdhury,et al. Evolution of adenoviruses as gene therapy vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] B. Thimmapaya,et al. High-efficiency adenovirus-mediated in vivo gene transfer into neonatal and adult rodent skeletal muscle , 2002, Journal of Neuroscience Methods.
[45] In-Hoo Kim,et al. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Shiotani,et al. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector , 2001, Gene Therapy.
[47] E. Wolf,et al. Muscle-Specific Overexpression of the Adenovirus Primary Receptor CAR Overcomes Low Efficiency of Gene Transfer to Mature Skeletal Muscle , 2001, Journal of Virology.
[48] H. Herweijer,et al. Time course of gene expression after plasmid DNA gene transfer to the liver , 2001, The journal of gene medicine.
[49] I. Kovesdi,et al. The role of receptors in the maturation-dependent adenoviral transduction of myofibers , 2001, Gene Therapy.
[50] F. Farzaneh,et al. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] A. Theofilopoulos,et al. Immunotherapeutic gene transfer into muscle. , 2001, Trends in immunology.
[52] M. Uchino,et al. Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA , 2001, Gene Therapy.
[53] W. Russell,et al. Update on adenovirus and its vectors. , 2000, The Journal of general virology.
[54] P. Hallauer,et al. Skeletal muscle gene transfer: regeneration-associated deregulation of fast troponin I fiber type specificity. , 2000, American journal of physiology. Cell physiology.
[55] R. Samulski,et al. The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers. , 2000, Human gene therapy.
[56] A. P. Alivisatos,et al. A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides , 1999 .
[57] A. Amalfitano,et al. Next-generation adenoviral vectors: new and improved , 1999, Gene Therapy.
[58] E. Hoffman,et al. Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. , 1999, Human gene therapy.
[59] G. Pari,et al. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. , 1999, Human gene therapy.
[60] T. Matsunaga,et al. Biomagnetic nanoparticle formation and application , 1998 .
[61] J. Glorioso,et al. Implications of maturation for viral gene delivery to skeletal muscle , 1998, Neuromuscular Disorders.
[62] D. Brough,et al. Adenoviral vectors for gene transfer. , 1997, Current opinion in biotechnology.
[63] Simon C Watkins,et al. Gene transfer to muscle using herpes simplex virus-based vectors , 1997, Neuromuscular Disorders.
[64] Simon C Watkins,et al. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers , 1996, Journal of virology.
[65] A. Bangham. Surrogate cells or Trojan horses. The discovery of liposomes. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[66] Xiang Gao,et al. Cationic liposome-mediated gene transfer. , 1995, Gene therapy.
[67] Hanns Lochmüller,et al. Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. , 1995, Experimental and molecular pathology.
[68] G. Acsadi,et al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. , 1994, Human molecular genetics.
[69] G. Prince,et al. The molecular basis of adenovirus pathogenesis. , 1994, Infectious agents and disease.
[70] P. Tonali,et al. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. , 1993, Human gene therapy.
[71] G. Acsadi,et al. Persistence of plasmid DNA and expression in rat brain cells in vivo , 1992, Experimental Neurology.
[72] R. Feynman. There’s plenty of room at the bottom , 1992, Journal of Microelectromechanical Systems.
[73] G. Repetto,et al. Direct gene transfer into nonhuman primate myofibers in vivo. , 1992, Human gene therapy.
[74] A. Miller,et al. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.
[75] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[76] P. Yurchenco,et al. Assembly of Basement Membranes a , 1990, Annals of the New York Academy of Sciences.
[77] A. Gabizon,et al. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[78] N. Muzyczka,et al. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[79] K. Kandori,et al. Preparation and characterization of monodisperse magnetite sols in microemulsion , 1983 .
[80] G. Rubin,et al. Transposition of cloned P elements into Drosophila germ line chromosomes. , 1982, Science.
[81] K. Widder,et al. Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1 , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[82] F. Graham,et al. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.
[83] R. Huebner,et al. Isolation of a Cytopathogenic Agent from Human Adenoids Undergoing Spontaneous Degeneration in Tissue Culture , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[84] O. Mykhaylyk,et al. Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes. , 2012, Biomaterials.
[85] T. D. Gruijl,et al. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep. , 2012 .
[86] Christian Plank,et al. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro , 2007, Nature Protocols.
[87] Huang Liu-yu,et al. Transposon-Based Strategies For Microbial Functional Genomics , 2006 .
[88] S. Kochanek,et al. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero , 2005, Gene Therapy.
[89] A. Józkowicz,et al. Helper-dependent adenoviral vectors in experimental gene therapy. , 2005, Acta biochimica Polonica.
[90] T. Daly. Overview of adeno-associated viral vectors. , 2004, Methods in molecular biology.
[91] J. Glorioso,et al. Delivery using herpes simplex virus: an overview. , 2004, Methods in molecular biology.
[92] N. Somia. Gene transfer by retroviral vectors: an overview. , 2004, Methods in molecular biology.
[93] M. Rudnicki,et al. Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.
[94] N. Somia. Gene Transfer by Retroviral Vectors , 2004 .
[95] J Henke,et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.
[96] R. Proulx,et al. A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle , 2000, Gene Therapy.